News for '-api'

CBI books NDA principal, 4 teachers for fudging records for appointment

CBI books NDA principal, 4 teachers for fudging records for appointment

Rediff.com7 Jun 2018

The agency had registered a preliminary enquiry in 2017 on the basis of allegations that 13 faculty members of the academy were appointed in spite of being ineligible.

PharmEasy buys Medlife, becomes largest e-pharma company

PharmEasy buys Medlife, becomes largest e-pharma company

Rediff.com26 May 2021

PharmEasy has acquired Medlife for an undisclosed amount, the e-pharmacy unicorn said on Tuesday. The deal will make PharmEasy the largest player in the domestic online pharmacy sector, with the combined entity set to serve 2 million customers a month.

Sputnik V vaccine may be added to India's Covid armoury soon

Sputnik V vaccine may be added to India's Covid armoury soon

Rediff.com30 Mar 2021

'We expect to get the approval in the next few weeks,' says Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy's Laboratories (DRL).

Aadhaar looking to go global

Aadhaar looking to go global

Rediff.com3 Dec 2021

The Unique Identification Authority of India (UIDAI) is looking to collaborate with foreign countries and international organisations to build digital identity systems across the world, a top official said on Friday. UIDAI CEO Saurabh Garg during a panel discussion with Paytm founder Vijay Shekhar Sharma at the Infinity Forum said the authority is also exploring emerging technology to enhance security and increase the number of transactions that can be done by using Aadhaar. "We think going forward we will be happy to collaborate with other nations...We would like to collaborate with international organisations also in building international institutions for standards for national identity.

Markets: 'Volatility to remain higher than usual'

Markets: 'Volatility to remain higher than usual'

Rediff.com3 Jun 2022

'Periods of high volatility are usually bad for mid-caps and this is something that has to be kept in mind.' 'Focus on quality is of paramount importance.'

Govt lifts export ban on anti-malarial drug HCQ

Govt lifts export ban on anti-malarial drug HCQ

Rediff.com18 Jun 2020

Indian Council of Medical Research had also recommended the use of hydroxychloroquine for treating healthcare workers handling suspected or confirmed coronavirus cases and also the asymptomatic household contacts of the lab-confirmed cases.

Can RBI's digital currency replace physical cash?

Can RBI's digital currency replace physical cash?

Rediff.com15 Dec 2022

Despite the demonetisation of 2016 and the rise in digital transactions that followed, the economy's dependence on cash has remained as high as ever. So when the Reserve Bank of India (RBI) introduced a pilot project of its version of digital cash - called the central bank digital currency (CBDC) - on December 1, many questions were asked. Can the CBDC replace physical cash, even partially? Can it match cash in terms of convenience? Are CBDC transactions truly anonymous?

10 Most Relevant Job Skills For 2023

10 Most Relevant Job Skills For 2023

Rediff.com2 Jan 2023

Siva Prasad Nanduri, chief business officer, TeamLease Digital, outlines the skills that will help you get a job in 2023.

World's biggest 3D printed building opens in Dubai

World's biggest 3D printed building opens in Dubai

Rediff.com17 Feb 2020

The two-storey 6,900 square foot structure will be used as an office for general administrative functions by the Dubai Municipality. It was designed in collaboration with Apis Cor, a 3D printing and construction company in Boston.

Gujarat pharma hub hit by near-zero exports

Gujarat pharma hub hit by near-zero exports

Rediff.com15 Apr 2020

With the government asking the companies to operate with only 50 per cent staff strength, and exports dipping to almost zero, the truck and bus drivers idling at the petrol pump say they hardly have any work now. At a petrol pump on the deserted Bavla-Changodar highway near Ahmedabad in Gujarat, several trucks and buses are neatly parked in a row.

NCP makes it clear, Anil Deshmukh won't step down

NCP makes it clear, Anil Deshmukh won't step down

Rediff.com21 Mar 2021

NCP Maharashtra chief Jayant Patil said on Sunday that Mumbai Home Minister Anil Deshmukh will not step down.

Lessons from Justdial 'data breach'

Lessons from Justdial 'data breach'

Rediff.com26 Apr 2019

At a time when services are rapidly digitising in India, enterprises are witnessing a rise in cases of sensitive data exposure risks and breaches.

Coronavirus outbreak: Domestic drug market stares at supply crisis

Coronavirus outbreak: Domestic drug market stares at supply crisis

Rediff.com20 Feb 2020

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Drug regulator to make routine inspection of Chinese suppliers

Drug regulator to make routine inspection of Chinese suppliers

Rediff.com15 Nov 2013

Move follows a spate of international regulatory enforcements on Indian drug firms.

Urgent need to keep adequate oxygen stock ready: Centre to states

Urgent need to keep adequate oxygen stock ready: Centre to states

Rediff.com12 Jan 2022

The Union health ministry said the emerging scenario calls for immediate measures by states and UTs to ensure optimal availability of medical oxygen at all health facilities.

Should you invest in these 5 stocks?

Should you invest in these 5 stocks?

Rediff.com26 Aug 2020

These five stocks, which have lagged the markets over the last two years, have doubled in value since March 23.

Mumbai cop Sachin Waze suspended

Mumbai cop Sachin Waze suspended

Rediff.com15 Mar 2021

The National Investigation Agency arrested Waze on Saturday night in connection with its probe into the recovery of a Scorpio containing 20 gelatin sticks near Mukesh Ambani's home on February 25.

How India Inc must change to serve digital customers

How India Inc must change to serve digital customers

Rediff.com25 Sep 2017

Technology, which was responsible for creating the new-age digital consumer issue for enterprises, also acts as a solution to the problem, says Karthick Viswanathan.

Extortion case filed against Mumbai DCP Akbar Pathan, two others

Extortion case filed against Mumbai DCP Akbar Pathan, two others

Rediff.com26 Aug 2021

Police have filed an extortion case against Mumbai Deputy Commissioner of Police Akbar Pathan and two other cops, one of them arrested for the killing of businessman Mansukh Hiran, on a complaint by a man who is an accused in a cheating case, an official said on Thursday.

Thane court asks Maha ATS to stop Mansukh Hiran death probe

Thane court asks Maha ATS to stop Mansukh Hiran death probe

Rediff.com24 Mar 2021

A Thane court on Wednesday directed the Maharashtra Anti-Terrorism Squad (ATS) to stop its investigation into the death of businessman Mansukh Hiran and hand over case records to the National Investigation Agency immediately.

Deshmukh was in hospital from Feb 5 to 15: Pawar rubbishes Singh's claims

Deshmukh was in hospital from Feb 5 to 15: Pawar rubbishes Singh's claims

Rediff.com22 Mar 2021

Singh on Saturday wrote a letter to Maharashtra Chief Minister Uddhav Thackeray, alleging that Deshmukh had indulged in "malpractices" and asked suspended API Sachin Waze to collect Rs 100 crore every month.

Made a killing in stocks? Algos could be behind it

Made a killing in stocks? Algos could be behind it

Rediff.com6 Dec 2017

A little over 80 per cent of the orders placed on domestic stock markets are generated by algorithms. Samie Modak reports on the whats and whys of algos.

Why Thyrocare sold out to PharmEasy

Why Thyrocare sold out to PharmEasy

Rediff.com5 Jul 2021

'I have done enough work for many years.' 'This is a decision that many people at my age need to review.' 'I may become an exit example for people to study.'

What India needs to become $5 trn economy

What India needs to become $5 trn economy

Rediff.com14 Sep 2021

India will need $8 trillion (around Rs 588 lakh crore) of gross capital formation or new greenfield assets to become a $5 trillion (around Rs 368 lakh crore) economy by FY2027, a report said. The report by Deloitte said despite the COVID-19 disruption, FDI inflow into the country provides necessary optimism and display underlying strengths of the Indian economy. In FY2020-21, FDI inflows (including equity, re-invested earnings, and capital) amounted to a record $81.72 billion, 10 per cent higher than the previous financial year, it said.

Niti Aayog on how India can protect personal data

Niti Aayog on how India can protect personal data

Rediff.com3 Sep 2020

India needs a paradigm shift in personal data management that transforms the current organisation-centric data sharing system to an individual centric approach that promotes user control on data sharing for empowerment, said Niti.

Indian drugmakers to pay higher facility fees on US hike

Indian drugmakers to pay higher facility fees on US hike

Rediff.com3 Aug 2014

The US laws authorise the drug and health watchdog to assess and collect user fees for certain applications and supplements for human generic drug products

Hiran death: ATS arrests cop, bookie; says Waze main accused

Hiran death: ATS arrests cop, bookie; says Waze main accused

Rediff.com21 Mar 2021

In a 'major breakthrough', the Maharashtra Anti-Terrorism Squad (ATS) has arrested a policeman and a bookie in connection with the alleged murder of businessman Mansukh Hiran, an official said on Sunday, adding Mumbai police officer Sachin Waze had played a key role in the crime and emerged as the prime accused.

NIA files chargesheet against Sachin Waze in Antilia-Hiran case

NIA files chargesheet against Sachin Waze in Antilia-Hiran case

Rediff.com3 Sep 2021

Besides Waze, former 'encounter specialist' Pradeep Sharma and a few other former police personnel are also accused in the case.

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Indian pharma cos get a shot in the arm in $12-bn Australian drug market

Rediff.com29 Apr 2022

Indian drug firms get a shot in the arm in the $12 bn Australian drug market as the Therapeutic Goods Administration (TGA), Australia agrees to accelerate the drug approval process in that country for Indian players who already have an approved plant and product from one of the stringent regulatory authorities like US, EU or Canada. From current sales of $340 mn, the Indian firms can see a significant upside in sales; felt Dinesh Dua, former chairman of the Pharmaceutical Exports Promotion Council of India (Pharmexcil), and the MD of Nectar Lifesciences. He highlighted that only 12 percent of the Australian drug market is generic, as against 80-90 per cent in the US or EU. Of this $1.5 bn generic drug market in India, Indian companies have a small share.

'There could be a bigger plan to teach Ambani a lesson'

'There could be a bigger plan to teach Ambani a lesson'

Rediff.com24 Mar 2021

'...to give him a signal that you cannot ignore Maharashtra, you are too close to the Centre.' 'I can see some kind of rivalry also in this, but it is better that the NIA goes deep into it.'

A peek into Mastercard's ambitious plan for India

A peek into Mastercard's ambitious plan for India

Rediff.com15 Feb 2019

Mastercard is keen on being known not as a payments player but a technology company.

Court sends Waze to judicial custody till April 23

Court sends Waze to judicial custody till April 23

Rediff.com9 Apr 2021

The NIA has said its investigation has revealed Waze and other accused had hatched a conspiracy to eliminate Hiran on March 2 and 3.

Sania Mirza: Fit, fab and pregnant!

Sania Mirza: Fit, fab and pregnant!

Rediff.com22 May 2018

Sania Mirza's sister, Anam showed off her working out.

Why US' revocation may not have much effect on HCQs exports

Why US' revocation may not have much effect on HCQs exports

Rediff.com17 Jun 2020

This is because while the emergency authorisation for treating Covid was a recent move, the drug has been used since years for rheumatoid arthritis and autoimmune lupus.

Cong, NCP demand CBI reveal outcome in Sushant case

Cong, NCP demand CBI reveal outcome in Sushant case

Rediff.com14 Jun 2021

The Congress and the Nationalist Congress Party, allies in the Shiv Sena-led Maha Viaks Aghadi government in Maharashtra, on Monday demanded that the Central Bureau of Investigation reveal its final finding into the Sushant Singh Rajput death case.

'Police and politicians are together in the notorious hafta system'

'Police and politicians are together in the notorious hafta system'

Rediff.com24 Mar 2021

'Param Bir's letter alleges that Waze was being used directly by the home minister.' 'I think an enquiry by a high court judge is the need of the hour.'

Bulk drug prices may rise this fiscal

Bulk drug prices may rise this fiscal

Rediff.com15 Apr 2014

The industry feels that prices of active pharmaceutical ingredients (APIs) can go up in the range of 5-15 per cent.

Hydroxychloroquine exports only to foreign govts, not pvt cos

Hydroxychloroquine exports only to foreign govts, not pvt cos

Rediff.com10 Apr 2020

India will export anti-malarial drug hydroxychloroquine, high in demand globally, only to foreign governments and not to private companies, as the product is under prohibited or banned category of exports, sources said. Although exports of this medicine is completely banned, India has decided to export this anti-malarial drug in sync with its global commitment to deal with the coronavirus pandemic.

Jhunjhunwala-backed Star Health's IPO scrapes through

Jhunjhunwala-backed Star Health's IPO scrapes through

Rediff.com3 Dec 2021

Star Health and Allied Insurance's Rs 7,250-crore initial public offering (IPO), the third largest this year and eighth largest ever, just about managed to make it despite a poor response from investors, garnering just 79 per cent subscription, forcing the investment bankers to prune offer for sale (OFS) component. This is the second large offering after digital payments major Paytm this year to receive a lukewarm response from investors, a sign that despite the IPO frenzy investors are discerning when it comes to pricing. As Star Health didn't meet the profitability criteria, its IPO required a mandatory 75 per cent subscription from qualified institutional buyers (QIB).

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Amid rise in Covid cases, Centre prohibits exports of Remdesivir

Rediff.com11 Apr 2021

Remdesivir is considered a key anti-viral drug in the fight against Covid-19. In addition, the government has taken three steps to ensure easy access of hospitals and patients to Remdesivir.